Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg

NCT06719986 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Overdose

Interventions

DRUG: Nalmefene HCl injection
DRUG: Naloxone HCl intranasal

Sponsor

Purdue Pharma LP